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1. Introduction  
Acyl-CoA Thioesterases (ACOTs) perform a wide range of cellular functions by catalysing 
the thiolytic cleavage of activated fatty acyl-CoAs. Substrates of ACOTs include short to 
long-chain acyl-CoAs as well as a range of methyl-branched, and dicarboxylic bile acid-
CoAs (M. C. Hunt & Alexson, 2008). Expression of ACOTs have been detected in both 
prokaryotes and eukaryotes with expression in higher organisms being detected in cytosol, 
mitochondria, peroxisomes and endoplasmic reticulum (J. Yamada, 2005).  
Within the ACOT enzyme family, one member in particular, ACOT7 has recently been 
identified as playing a role inflammation through the production of arachidonic acid (AA). 
It was recently proposed that ACOT7-mediated AA production may provide a 
complementary source of AA to the well characterised phospholipase A2 (PLA2) pathway 
(Satoru Sakuma, Usa, & Fujimoto, 2006); see Table 1 for review of Acot substrate specificity. 
Evidence for these observations was through experimental data showing that ACOT7 
possessed high substrate specificity for AA-CoA; the gene encoding ACOT7 was highly 
expressed in macrophages and up-regulated when stimulated by lipopolysaccharide (LPS); 
and that over-expression of the enzyme lead to an increase in prostaglandin production. 
Together, these observations highlight a novel role of ACOT7 in inflammation through the 
production of arachidonic acid from the thiolytic cleavage of activated polyunsaturated 
omega-6 fatty acid C20:4-CoA (Forwood et al., 2007). 
2. Cellular production of arachidonic acid (C20:4) 
Arachidonic acid has a number of important cellular roles, namely in cell signalling, 
regulation of metabolic and signalling enzymes, and inflammation.  Despite its importance, 
its methods of cellular production are not fully understood.  The most well characterised 
cellular pathway for arachidonic acid involves its release from membrane phospholipids via 
the action of PLA2, an enzyme responsible for the catalysis and hydrolysis of phospholipids 
at the sn-2 position (Sakuma et al, 2006) (see Figure 1).  
Expression of PLA2 is regulated according to the requirement for arachidonic acid and well 
understood. Rapid activation of PLA2 is achieved via posttranslational modification,  and 
enzyme activity is activated by phosphorylation (controlled by mitogen-activated protein), 
while prolonged expression is regulated at a transcriptional level by cytokines and growth 
factors such as macrophage colony stimulating factor, tumor necrosis stimulating factor- 
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Acot Homologue Preferred acyl-CoA substrate 
Acot1 Lauroyl and palmitoyl-CoA 
Acot2 Lauroyl and palmitoyl-CoA 
Acot3 Palmitoyl-CoA  
Acot4 Succinyl-CoA  
Acot5 Decanoyl-CoA  
Acot6 Not determined 
Acot7 Arachidonoyl-CoA 
Acot8 Bile acids  
Acot9 Myristoyl-CoA  
Acot10 Myristoyl-CoA  
Acot11 Not determined 
Acot12 Acetyl-CoA 
Acot13 Aromatic acyl-CoAs 
Table 1. Substrate specificities for acyl-coA thioesterases. 
alpha and glucocorticoid (Jiang et al., 2001; Satoru Sakuma, et al., 2006). While PLA2 is well 
known for its role in generating AA from the cleavage of the acyl bond of membrane 
phospholipids in a range of cell types, several lines of evidence have recently developed to 
suggest that PLA2 may not be solely responsible for controlling AA levels. For example, it 
was shown that AA-CoA can supply AA for prostaglandin (PG) synthesis (S. Sakuma et al., 
1994), and that a novel enzymatic pathway exists whereby thioesterase cleavage of AA-CoA 
is responsible for supplying free AA to be utilised in the synthesis of prostaglandins (S. 
Sakuma, et al., 1994). A similar mechanism has also been described for controlling cellular 
levels of AA where it was demonstrated that AA levels were under the control of competing 
actions of an acyl-CoA thioesterase and synthetase, independent of the classical PLA2 
cascade (Maloberti et al., 2005). In further support of these observations, when competition 
on AA levels were reduced through inhibition of an AA acyl-CoA synthetase (ACS; the 
opposite reaction that is catalysed by Acot7), substantial increases in PG levels were 
observed (Castilla et al., 2004); and moreover, in an independent study, overexpression of an 
acyl-CoA synthetase was been shown to cause a marked increase in synthesis of AA-CoA, 
increased 20:4 incorporation into membrane phospholipids, reduced cellular levels of 
unesterified 20:4, and reduced secretion of prostaglandin E2 (PGE2) while inhibition of the 
ACS resulted in increased release of PGE2 (Golej et al., 2011). Thus, it is emerging that 
inflammation is a complex cellular process, and PLA2 is unlikely to be the sole enzymatic 
pathway responsible for regulating AA levels, typically kept low due to the potent 
biological actions of the eicosanoids (Flesch, Schonhardt, & Ferber, 1989; Irvine, 1982), and 
that complementary pathways exist to contribute to AA generation and synthesis of 
eicosanoid inflammatory mediators during an immune response. That ACOT7 is 
abundantly expressed in macrophages and upregulated during an immune response; has 
high specificity for AA-CoA; and its over-expression in LPS-simulated macrophages cause 
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an increase in prostaglandin production, is consistent with the role of ACOT7 in 
inflammation through the production of AA-derived inflammatory mediators.  
 
 
Fig. 1. The cellular pathway of arachidonic acid release involves the phospholipaseA2, and 
other AA-producing pathways. 
2.1 Role of arachidonic acid in inflammation 
Cellular production of arachidonic acid is utilized in a range of pathways, including the 
generation of potent mediators to initiate an inflammatory response. Two well characterised 
pathways important in inflammation include the cyclooxygenase (COX) and 5-
Lipoxygnease pathways, and involve the conversion of arachidonic acid into prostanoids 
(prostaglandins, thromboxans), and leukotrienes respectively. The prostanoids include a 
range of arachidonic acid-derived metabolites that function to maintain body homeostasis 
by acting in a paracrine and autocrine fashion on cells within the vicinity of their release and 
are targets for the anti-inflammatory drugs including aspirin and derivatives. They typically 
exert their effect through activation of cell surface specific G-protein coupled receptors 
(GPCR), of which there are several subtypes for each prostanoid: PGD receptor (DP); PGE 
receptors EP1, EP2, EP3 and EP4 subtypes; PGF receptor (FP); PGI receptor (IP); and TX 
receptor (TP). There is also a receptor found on Th2 cells (CRTH2) that reacts to PGD2 but 
belongs to the chemokine receptor family (Narumiya, 2009; Wang, Honn, & Nie, 2007).  
Prostanoid production is increased during the inflammation response, particularly during 
acute inflammation, prior to the recruitment of leukocytes. There are a number of different 
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prostanoids produced from the COX pathway, including prostaglandin (PG) D2, 
prostaglandin E2 (PGE2), prostaglandin F2alpha (PGF2┙), prostacyclin (PGI2) and thromboxane 
(TX) A2 (Narumiya, 2009). Gilroy et al. found that PGE2 levels are raised only during the 
initial phases of inflammation whilst PGD2 becomes the predominant prostanoid during the 
final stages of the inflammatory response (Gilroy et al., 1999; Tilley, Coffman, & Koller, 
2001). 
5-lipoxygenase utilises free arachidonic acid in conjunction with 5-lipoxygenase activating-
protein (FLAP), the 5-lipoxygenase activating protein, to catalyse the oxygenation of 
arachidonic acid into hydroperoxy-eicosatetraenoic acid (HPETE). FLAP selectively 
transfers arachidonic acid to 5-lipoxygenase and enhances the sequential oxygenation of this 
substrate to produce 5(S)-hydroperoxyeicosatetraenoic acid (5HpETE), as well as 
dehydration of arachidonic acid to leukotriene A4 (LTA4). LTA4 can then be exported from 
the cell and undergo transcellular metabolism or be converted into either the pro-
inflammatory LTB4 or into a cysteinyl leukotrienes (cysLTs) LTC4, LTD4 or LTE4. The 
cysteinyl leukotrienes are a family of bronchoconstrictive, vasoconstrictive pro-
inflammatory molecules. The primary signalling method for these leukotrienes is the 
activation of GPCRs on cell surfaces, namely BLT1 and BLT2 forLTB4, and CysLT1 and 
CysLT2 for CysLT’s. Leukotrienes are thought to play a role in innate immune defence as 
well as a role in antimicrobial host defence. Importantly, they have been shown to play a 
role in respiratory diseases, such as asthma, allergies, such as anaphylaxis (Ferreira et al., 
2008), as well as cardiovascular disease (Evans, Ferguson, Mosley, & Hutchinson, 2008). 
Cytochrome P450 is thought to act on endogenous arachidonic acid converting it into epoxy-
eicosatrienoic acids (EETs) (Piomelli, 2000). Although found primarily in the liver 
cytochrome P450 has also been detected in a number of different tissues such as lungs, 
kidney, skin, adrenal cortex and brain tissues. The implications of P450 in the brain were 
demonstrated by Nicholson & Renton (2005) by removing astrocytes from rat brains and 
demonstrating that levels of P450 are modulated by inflammation using LPS stimulation.  
Peroxisome-proliferator-activated receptors (PPARs) ┙ and ┛ regulate the transcription of 
target genes through agonist binding to the ligand-binding domain (LBD) of these genes. 
PPAR┙ plays a role in fatty acid regulation, through modulating the expression of target 
genes, and are characterised by a high lipid catabolic activity. Jiang et al. (2001) found that 
clofibrate, which activates PPAR┙, up-regulates the expression of cPLA2 and COX-2 in 
preadipocytes. PPAR┛ has been shown to play a role in the regulation of differentiation of 
preadipocytes into adipocytes. It was found by Murakami et al. (2001) that fatty acyl-CoA’s 
function as antagonists for PPAR┙ and PPAR┛. 
3. Acyl-CoA thioesterase activity 
Acyl-CoA’s perform a wide range of important cellular functions, serving as primary 
substrates for fatty acid degradation and lipid synthesis as well as regulators of cellular 
mechanisms such as ion fluxes, vesicle trafficking, protein phosphorylation and gene 
expression (see Figure 2 for domain organisation of Acot family members).  
Most recently, the action of a specific enzyme within the ACOT enzyme family was 
demonstrated to act on arachidonoyl-CoA, and therefore possibly play a role in arachidonic 
acid production for the generation of prostanoids and leukotrienes.  This is achieved by 
cleaving the thioester bond of activated C20:4-CoA in the general reaction described in 
Figure 3. 
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Fig. 2. Domain organisation of Acots. 
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Fig. 3. ACOTs hydrolyse acyl-CoA esters to form free fatty acids and CoASH 
3.1 Activity of ACOT7 
It has been demonstrated that ACOT7 cleaves arachidonoyl-CoA to release CoA as CoASH 
and the free fatty acid arachidonic acid. Arachidonic acid is the precursor for a number of  
eicanosoids that enable the activation of macrophages (Kirkby, Roman, Kobe, Kellie, & 
Forwood, 2010), and it has been shown that ACOT7 expression is upregulated in 
macrophages in the presence of LPS and colony-stimulating factor 1 (CSF-1) (2007). It is 
from this data that the putative role of ACOT7 in inflammation was recognised. As shown 
in figure 4 below, ACOT7 may provide an alternative pathway for inflammation to the well 
characterised PLA2-mediated pathway and a possible target for a new class of anti-
inflammation therapies. 
Fujita et al. (2011) found that levels of both cytosolic and mitochondrial ACOT7 within 
mammalian heart muscle increase in response to a high fat diet, and induce inflammation. 
The increased levels of ACOT7 are in response to the increasing levels of acyl-CoA 
imported across the mitochondrial membranes from the cytosol via the action of carnitine 
plamitoyltransferase (CPT). This mechanism is thought to reduce the “lipotoxic” effects of 
insulin resistance which leads to contractile dysfunction of the heart as the cells 
accumulate proinflammatory molecules such as acyl-CoA, diacylglycerol and ceramide 
(Fujita, et al., 2011).  
ACOT7 is also known as brain acyl-CoA hydrolase (BACH) and has been purified from the 
brain cytosol of rats and humans and is believed to be responsible for acyl-CoA hydrolytic 
activity in the brain. Given the highly toxic nature of long chain acyl-CoA’s, as a detergent, 
the activity of ACOT7 within the brain may be to reduce the levels of these within neurons 
(Kuramochi et al., 2002). Furthermore  Takagi et al. (2006) found that ACOT7 is expressed in 
mouse testis and may play a role in spermatogenesis. The results of this research suggest 
that the regulation of ACOT7 occurs at a posttranscriptional level or that the rate of turnover 
in the testis is higher than in the brain. The level of ACOT7 protein was higher in the brain 
than the testis however the mRNA level was higher in the adult testis than the brain. The 
physiological significance of ACOT7 within the testis has not been determined however it is 
thought to scavenge cytosolic free long-chain acyl-CoA’s.  
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Fig. 4. Classical pathway of inflammation with role of ACOT7 in arachidonic acid 
production.  
4. Structure of ACOT7 
Structural insights into the function of ACOT7 have recently been undertaken through the 
cloning and high-level recombinant expression of ACOT7. Pioneering characterisation of 
ACOT7 was undertaken by Yamada et al. (1994) through the isolation and purification of rat 
liver, however high level over-expression and isolation of the enzyme required cloning of 
cDNA into bacterial expression vectors (Broustas, Larkins, Uhler, & Hajra, 1996; Junji 
Yamada et al., 1999). Serek et al. (2006) elucidated the structure of the C-terminal of the 
ACOT7 protein purified from Mus musculis by crystallising the C-terminal domain and 
analysing the high resolution structure using X-Ray diffraction techniques. From this data it 
was identified that the C-terminal domain of ACOT7 exists in a hexameric form. Forwood et 
al (2007) isolated and expressed both the N- and C-terminals of ACOT7. These domains 
were then separately crystallised and the resulting structures (in 1.8 and 2.5 Å resolution 
respectively) were superimposed to determine the structure of the full length ACOT7. 
Within the hexamer of Acot7 ┚-sheets from each domain form a semicontinuous antiparallel 
barrel with 25% of Acot7 residues involved in interdomain contacts (see Figure 5).  
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Fig. 5. Structure of full-length Acot7 showing monomer and trimer arrangement. 
Wedged between the two monomers that make up the protomer are six CoA molecules, 
making contacts with residues from each domain. Opposite this binding site is a large 
hydrophobic tunnel, conserved within thioesterases that may be involved in the fatty-acid 
recognition and release. The individual domains are inactive when in homomeric 
complexes however when combined the activity can be restored to half that of the wild 
type enzyme. The arrangement of the N- and C-domains within ACOT7 and the 
positioning of the CoA molecules within the N-domain suggest that the full molecule 
contains three copies each of two distinct active sites in ACOT7. There are two potential 
active sites within ACOT7 (sites I and II, see Figure 6); these were determined via 
sequence analysis of mammalian ACOT7s.  To assess the role that each of these active 
sites play in catalysis each residue was mutated to Ala and the recombinant mutant 
enzymes were isolated and the activity of the mutant residues determined. The mutations 
in site I resulted in dramatic reductions in catalytic activity, whereas the analogous 
mutations in site II did not affect activity. These findings demonstrated that site II were 
not directly involved in catalysis. Furthermore the introduction of the key catalytic 
residues from site I into site II resulted in a four-fold increase in catalytic activity when 
compared with the wild-type Acot7. Thus, Acot7 (structures of each domain presented in 
figure 7) is believed to contain a “half-of-sites” activity, which may regulate the enzyme 
by placing an upper limit on enzyme efficiency and allows the cell to regulate the cellular 
concentrations of AA-CoA and arachidonic acid.  
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5. Genetic regulation of ACOTs   
The acyl-CoA thioesterase gene (ACOT) family encodes for two specific types of enzyme, 
acyl-CoA thioesterase type I and type II, which are determined by differences in structure 
and sequence. These two types catalyse similar reactions but share no similarity in structure 
or function, demonstrating that they are analogous and not homologous. They are an 
example of convergent evolution, whereby two molecules have evolved to fill the same need 
within the cell. Type I ACOT proteins are members of the ┙/┚ hydrolase fold enzyme 
superfamily. This superfamily also includes a number of esterase-activity-inhibiting 
enzymes such as carboxyl-esterase’s and lipases. This group is comprised of only four genes; 
ACOT1, ACOT2, ACOT4 and ACOT6. These proteins share a high degree of sequence 
homology, all forming an 80 kilobase gene cluster on chromosome 14q24.3, demonstrating 
that they have arisen as a result of gene duplication.  Within the mouse and rat orthologues 
there is a similar phenomenon; Acot1, Acot2, Acot3, Acot4, Acot5 and Acot6 are clustered on 
chromosomes 12 D3 within the mouse and 6q31 within the rat. This can be seen in figure 8 
below which also demonstrates the cellular compartments in which each is expressed 
(Brocker, Carpenter, Nebert, & Vasiliou, 2010).  
Type II ACOTs are members of the ‘hot dog’ fold enzyme superfamily. The type II ACOTs 
are far less related than the type I ACOTs. There is only one type II ACOT that does not 
contain a double ‘hot dog’ domain suggesting that they may have evolved as a gene 
duplication event, allowing for the accommodation of bulky substrates. Type II ACOTs 
show highly divergent sequences making evolutionary comparisons difficult without three-
dimensional structures, as structural interaction conservation does not directly correspond 
with residue conservation. Within the mouse genome there is an additional type II ACOT, 
known as Acot10, which shares 95% mRNA identity with ACOT9. The other seven type II 
ACOT genes are highly conserved among human, mouse and rat indicating that they were 
all present in the ancestor preceding mammalian radiation (Brocker, et al., 2010; M. C. Hunt 
& Alexson, 2008; Kirkby, et al., 2010).  
5.1 Expression and regulation of ACOT7 
The ACOT7 enzyme is highly conserved, exhibiting greater than 95% sequence homology 
at the amino acid level between human, mice and rats (Kuramochi et al., 2002). 
Transcription start sites for ACOT7 were characterised by Takagi et al. in 2004 and shown 
to encode a 43kDa subunit, located in the cytosol; and six isoforms comprised of 50kDa 
subunits, expressed at trace levels and located in the mitochondria. Independent studies 
have confirmed that the ACOT7 gene can generate up to seven different protein isoforms 
as can be seen below in figure 6 (J. Yamada, 2005). The human ACOT7 gene consists of 13 
exons, with the first four of these able to be used as first exons. The most well 
characterised of the ACOT7 isoforms, ACOT7a, is derived from the sequence 
corresponding to transcription initiation at exon 2 (M. Hunt et al., 2007; Kirkby, et al., 
2010).   
Expression of ACOT7 has been detected in the developing mouse embryo brain as early as 
embryonic 11.5 days although in very low concentrations and increases until day seven 
following birth. Thereafter the level declined until day 28 following birth when it reached 
a steady state which was about 70% of its highest expression (on day 7) and identical to  
www.intechopen.com
 Inflammatory Diseases – A Modern Perspective 212 
 
Fig. 6. Active sites of Acot7: Active site I is comprised of Asn24 from the N-domain and 
Asp213 from the C-domain; the analogous site (later determined to be inactive) is comprised 
of Glu39 from the N-domain and Thr198 from the C-domain 
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Fig. 7. (A) (B) Quaternary structure of Acot7 (N terminus) and C terminus respectively 
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Fig. 8. Full length Acot7 demonstrating the N terminus domain (in green) and C terminus 
domain (in purple) 
levels recorded at birth. The expression of ACOT7 was located only in cells committed to 
neuronal lineage, and continues to be expressed in these cells resulting in the high 
expression of ACOT7 in the adult brain (Junji Yamada, Kuramochi, Takagi, & Suga,  
2004). 
Research by Takagi, Suto, Suga & Yamada (2005) showed that ACOT7 gene expression is 
regulated by Sterol Regulatory Element-Binding Proteins (SREBPs). SREBPs form a few 
transcription factors which play a critical role in the regulation of cholesterol and fatty acids. 
Within the cell SREBPs are located in the membrane, to enter the nucleus they undergo 
proteolytic cleavage and their N-terminals are released as nSREBPs. Within the nucleus 
SREBPs bind to the sterol regulatory element (SRE) of target genes. The BACH gene 
promoter region contains two SRE motifs providing a binding partner for nSREBPs 
stimulating the production of cDNA of Acot7 (Takagi, et al., 2005).  
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Fig. 9. The type I acyl-CoA thioesterase gene cluster is found on chromosome 14q24.3 in the 




Fig. 10. Structural organisation of the human BACH gene, exons are designated by blue 
boxes and introns by red segments, adapted from Yamada et al. (2005) 
6. Conclusion 
Inflammation is a complex immune response that involves the production of eicosanoids via 
AA. The cellular role of ACOT7 has been extended to include the cleavage of 
arachidonoyl:CoA to yield arachidonic acid, and therefore may provide a mechanism for the 
supply of arachidonic acid from intracellular arachidonoyl-CoA. This is supported by a 
number of lines of evidence: ACOT7 is highly expressed in macrophages and upregulated 
by proinflammatory stimuli; the preferred substrate of ACOT7 is arachidonoyl-CoA and the 
reaction product is the central precursor for lipid inflammatory mediators; and finally, over-
expression of ACOT7 in activated macrophages increases prostaglandin production.  Thus, 
ACOT7 is able to complement the well-characterised PLA2 AA-producing pathway, and 
Human Chromosome 14
Mouse Chromosome 12 
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may play a role in inflammation by producing sufficient levels of AA for eicosanoid 
production.  
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